Swaziland gets paediatric HIV/AIDS centre of excellence:
This article was originally published in Clinica
Executive Summary
Swaziland's first dedicated paediatric HIV/AIDS centre - the latest in a growing network of clinical excellence centres across Africa - opened this week. The project, a joint initiative between the government and the Baylor College of Medicine (Houston, Texas), with support from pharmaceutical group Bristol-Myers Squibb (BMS), aims to increase 11-fold the country's capacity to diagnose and treat HIV in children. These currently number around 16,000, according to UNICEF estimates. The Baylor-BMS partnership in Africa began in Botswana, where a similar centre opened in 2003. Others are being established in Burkina Faso and Uganda, due to open in 2007.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.